<HashMap><database>iProX</database><scores/><additional><omics_type>Proteomics</omics_type><submitter>Yuefeng Chu</submitter><species>Brucella Abortus 2308</species><full_dataset_link>http://www.iprox.org/page/project.html?id=IPX0016270000</full_dataset_link><submitter_email>chuyuefeng@caas.cn</submitter_email><submitter_affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences</submitter_affiliation><sample_protocol></sample_protocol><repository>iProX</repository><data_protocol></data_protocol><pubmed_abstract>Brucella species (&lt;i>Brucella&lt;/i> spp.) are facultative intracellular zoonotic pathogens responsible for brucellosis, a disease causing substantial global public health and economic burdens. Rifampicin remains a first-line therapeutic agent, but the molecular mechanisms underlying rifampicin resistance in &lt;i>Brucella&lt;/i> remain poorly defined, especially the contribution of ribosome-associated regulatory proteins. HflX is a conserved ribosome-binding GTPase involved in ribosomal quality control and antibiotic resistance, yet its role in rifampicin resistance has not been reported. Here, we constructed &lt;i>hflX&lt;/i> deletion and complemented strains of &lt;i>Brucella&lt;/i> abortus 2308 and characterized their phenotypes using antimicrobial susceptibility tests, growth and time-kill assays, electron microscopy, proteomics, and RT-qPCR. Deletion of &lt;i>hflX&lt;/i> significantly increased bacterial susceptibility to rifampicin, impaired growth recovery, and intensified intracellular stress without disrupting cell envelope integrity. Mechanistically, &lt;i>hflX&lt;/i> depletion led to coordinated downregulation of RNA polymerase (RNAP) core subunits (&lt;i>rpoA&lt;/i>, &lt;i>rpoB&lt;/i>, and &lt;i>rpoC&lt;/i>) and σ factors (&lt;i>rpoD&lt;/i> and &lt;i>rpoH&lt;/i>) at both protein and mRNA levels. Our findings demonstrate that HflX mediates rifampicin resistance in &lt;i>Brucella&lt;/i> by regulating RNAP-associated gene expression and metabolic adaptation, establishing a novel HflX-RNAP regulatory axis. This study expands the understanding of antibiotic resistance in intracellular pathogens and highlights HflX as a promising target for developing anti-resistance strategies against brucellosis.</pubmed_abstract><pubmed_title>HflX mediates rifampicin resistance in &amp;lt;i&amp;gt;Brucella&amp;lt;/i&amp;gt; by downregulating the expression of RNA polymerase-associated genes.</pubmed_title><pubmed_authors>Geng Hao H, Qi Mengzhu M, Su Mengru M, Zhi Feijie F, Chu Yuefeng Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>HflX mediates rifampicin resistance in Brucella by downregulating the expression of RNA polymerase-associated genes</name><description>To further investigate molecular changes associated with HflX knock during rifampicin exposure, we performed label-free quantitative proteomic analysis. The WT and ΔhflX strains were cultured for three generations in the presence of 1/2 MIC rifampicin (1 μg/mL) and harvested during the logarithmic growth phase, with at least three biological replicates per group. DIA-based proteomic analysis quantified protein abundance and identified differentially expressed proteins (DEPs) (Figure 5A). Bioinformatic analyses were then conducted to evaluate enriched pathways and co-expression networks, aiming to elucidate the regulatory role of HflX in Brucella.</description><dates><publication>Thu Mar 19 00:00:00 GMT 2026</publication></dates><accession>PXD075846</accession><cross_references><TAXONOMY>359391</TAXONOMY><pubmed>42063517</pubmed></cross_references></HashMap>